Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Alliance Pharma delays preliminary results

(Sharecast News) - International healthcare group Alliance Pharma announced the postponement of its preliminary results for the year ended 31 December on Monday. The AIM-traded firm said the results, initially scheduled for 23 April, would now be delayed until early May.

It said it expected to provide an update on the publication date by 26 April.

Following an earlier announcement on 5 April, Alliance Pharma informed shareholders that despite the advanced stage of the audit process, its auditor, Deloitte LLP, had requested more time to finalise their work.

"Alliance reiterates that the details provided in the full year trading update on 29 January remain accurate," the board said in its statement.

At 1414 BST, shares in Alliance Pharma were down 1.63% at 36.25p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

FY turnover and profits grow at Arcontech
(Sharecast News) - Software firm Arcontech said on Monday that full-year pre-tax profits and turnover were both anticipated to come in ahead of current market expectations.
Brave Bison pre-tax profits grow in H1
(Sharecast News) - Digital advertising company Brave Bison said on Monday that adjusted pre-tax profits had grown in the six months ended 30 June, leaving it confident of its ability to meet current market expectations for FY24.
Fonix Mobile ends year ahead of market expectations
(Sharecast News) - Mobile payments and messaging technology provider Fonix Mobile reported a strong full-year financial performance in a trading update on Monday.
Tristel flags forecast-busting full-year results
(Sharecast News) - Infection prevention products manufacturer Tristel released a robust trading update for the year ended 30 June on Monday, with revenues and pre-tax profits surpassing market expectations.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.